Rxo (RXO) Non-Current Debt (2022 - 2026)

Rxo (RXO) has reported Non-Current Debt for 5 consecutive years, with $459.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Debt rose 18.6% year-over-year to $459.0 million; the trailing twelve-month figure through Jun 2026 stood at $459.0 million (up 18.6% YoY), and the FY2025 full-year result was $387.0 million, up 10.26% from the prior year.
• Non-Current Debt climbed to $459.0 million in Q2 2026 per RXO's latest filing, from $430.0 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $459.0 million in Q2 2026 and bottomed at $6.0 million in Q3 2022.
• Historically, Non-Current Debt has averaged $376.7 million across 5 years, with a median of $387.0 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Non-Current Debt surged 7416.67% in 2023, then retreated 22.17% in 2024.
• Over 5 years, Non-Current Debt stood at $451.0 million in 2022, then declined by 21.06% to $356.0 million in 2023, then retreated by 1.4% to $351.0 million in 2024, then climbed by 10.26% to $387.0 million in 2025, then advanced by 18.6% to $459.0 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $459.0 million, $430.0 million, and $387.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.